logo
  Join        Login             Stock Quote

Quest Diagnostics Q4 Profit Miss Estimates, Guides 2013 Below Street

 January 23, 2013 08:08 AM
 


(By Mani) Quest Diagnostics, Inc. (NYSE: DGX) reported a lower fourth quarter profit that missed Wall Street estimates by a penny as Hurricane Sandy and restructuring charges weighed on results. The company also guided 2013 earnings and revenue below Street view.

For the quarter ended Dec.31, the company reported earnings attributable to common shareholders of $55.8 million, or 34 cents a share, compared to $189.5 million, or $1.19 a share, last year.

Hurricane Sandy reduced revenues by an estimated $21 million, operating income by an estimated $16 million and earnings per share by an estimated 6 cents. The company also recorded restructuring and integration costs of 14 cents a share.

Fourth quarter results include a benefit of 2 cents per share in 2012 and 8 cents in 2011 associated with discrete tax items. The company also reported loss from discontinued operations of $84.4 million, or 53 cents a share for the quarter.

Excluding items, adjusted income from continuing operations was $163 million, or $1.01 a share, compared to $191 million, or $1.20 a share, a year-ago.

Net revenues declined to $1.77 billion from $1.85 billion in the same quarter last year.

Wall Street expected earnings of $1.02 a share on revenue of $1.80 billion, according to analysts polled by Thomson Reuters.

Diagnostic information services revenues decreased 4.4 percent. Volume, measured by the number of requisitions, declined 2.4 percent and revenue per requisition was 2.0 percent below the prior year. The impact of Hurricane Sandy in the quarter is estimated to have reduced diagnostic information services revenues by 1.3 percen and volume by 1.0 percent.

For 2013, the company expects earnings from continuing operations, before special items, of $4.35 to $4.55 a share on revenue growth of between 0 percent and 1 percent. Analysts expect earnings of $4.81 a share on revenue of $7.53 billion, implying revenue growth of 1.1 percent.

Shares of Quest Diagnostics closed Tuesday's regular trading session at $61.83 on the NYSE.

iOnTheMarket Premium
Advertisement

Advertisement


Post Comment -- Login is required to post message
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
 

rss feed

Latest Stories

article imageHealth Net, Inc. (HNT): Potential to Be Huge Winners Says Bank of America

As of this keystroke, Health Net, Inc. (NYSE: HNT) shares are up around 4% on the day. The managed health read on...

article imageHomeAway, Inc. (AWAY) Q2 Earnings Preview: Top and Bottom Line Bullish Surprise?

HomeAway, Inc. (NASDAQ:AWAY) will report its financial results for the second quarter ended June 30, 2014 read on...

article imageAmazon.com, Inc. (AMZN) Q2 Earnings Preview: Missing on the Top and Bottom Lines, Again?

Amazon.com, Inc. (NASDAQ:AMZN) will release its second quarter financial results after market close on read on...

article imageFord Motor Company (F) Q2 Earnings Preview: Light on the Top Line?

Ford Motor Company (NYSE:F) will release its preliminary second quarter 2014 results at 6:30 a.m. EDT read on...

Advertisement
Popular Articles

Advertisement
Daily Sector Scan
Partner Center



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.